Novocure Ltd Equity Multiplier 5 year CAGR is 1.71% for the Trailing 12 Months (TTM) ending March 31, 2024, a -18.58% change year over year. The Equity Multiplier measures the proportion of a company's assets that are financed by equity. It indicates the level of financial leverage in a company's capital structure. A higher ratio suggests a higher level of debt financing and indicates higher financial risk. The equity multiplier is useful in assessing the company's solvency and financial stability. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.